治疗类风湿性关节炎的新药。 - Suppr

Suppr

超能文献

New drugs for rheumatoid arthritis.

作者信息

Roberts Lynden J

出版信息

N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61. doi: 10.1056/NEJM200412163512522.

DOI:10.1056/NEJM200412163512522

PMID:15602032

Abstract

摘要

相似文献

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61. doi: 10.1056/NEJM200412163512522.

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61.

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Aug 26;351(9):937-8. doi: 10.1056/NEJM200408263510922.

Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Arthritis Rheum. 2011 Jun;63(6):1479-85. doi: 10.1002/art.30310.

Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.

Prescrire Int. 2010 Feb;19(105):30-4.

Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?

J Rheumatol. 2006 Feb;33(2):433; author reply 433-4.

Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.

Prescrire Int. 2004 Oct;13(73):171-5.

Infliximab treatment of rheumatoid arthritis.

Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii. doi: 10.1016/j.rdc.2004.01.009.

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.

Rheumatology (Oxford). 2011 Dec;50(12):2311-3. doi: 10.1093/rheumatology/ker106a. Epub 2011 May 4.

Biologic therapy for early rheumatoid arthritis: the latest evidence.

Curr Opin Rheumatol. 2008 May;20(3):314-9. doi: 10.1097/BOR.0b013e3282f5fcf6.

引用本文的文献

Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis.

Arthritis Res Ther. 2005;7(3):111-3. doi: 10.1186/ar1746. Epub 2005 Mar 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61. doi: 10.1056/NEJM200412163512522.

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61.

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 Aug 26;351(9):937-8. doi: 10.1056/NEJM200408263510922.

Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Arthritis Rheum. 2011 Jun;63(6):1479-85. doi: 10.1002/art.30310.

Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.

Prescrire Int. 2010 Feb;19(105):30-4.

Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?

J Rheumatol. 2006 Feb;33(2):433; author reply 433-4.

Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.

Prescrire Int. 2004 Oct;13(73):171-5.

Infliximab treatment of rheumatoid arthritis.

Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii. doi: 10.1016/j.rdc.2004.01.009.

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.

Rheumatology (Oxford). 2011 Dec;50(12):2311-3. doi: 10.1093/rheumatology/ker106a. Epub 2011 May 4.

Biologic therapy for early rheumatoid arthritis: the latest evidence.

Curr Opin Rheumatol. 2008 May;20(3):314-9. doi: 10.1097/BOR.0b013e3282f5fcf6.

引用本文的文献

Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis.

Arthritis Res Ther. 2005;7(3):111-3. doi: 10.1186/ar1746. Epub 2005 Mar 30.